Rao Martin, Valentini Davide, Poiret Thomas, Dodoo Ernest, Parida Shreemanta, Zumla Alimuddin, Brighenti Susanna, Maeurer Markus
Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet.
Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S225-34. doi: 10.1093/cid/civ614.
The protective role of B cells and humoral immune responses in tuberculosis infection has been regarded as inferior to cellular immunity directed to the intracellular pathogen Mycobacterium tuberculosis. However, B-cell-mediated immune responses in tuberculosis have recently been revisited in the context of B-cell physiology and antigen presentation. We discuss in this review the diverse functions of B cells in tuberculosis, with a focus on their biological and clinical relevance to progression of active disease. We also present the peptide microarray platform as a promising strategy to discover unknown antigenic targets of M. tuberculosis that could contribute to the better understanding of epitope focus of the humoral immune system against M. tuberculosis.
在结核病感染中,B细胞和体液免疫反应的保护作用一直被认为不如针对细胞内病原体结核分枝杆菌的细胞免疫。然而,最近在B细胞生理学和抗原呈递的背景下,人们重新审视了结核病中B细胞介导的免疫反应。在本综述中,我们讨论了B细胞在结核病中的多种功能,重点关注它们与活动性疾病进展的生物学和临床相关性。我们还介绍了肽微阵列平台,这是一种有前景的策略,可用于发现结核分枝杆菌未知的抗原靶点,有助于更好地理解体液免疫系统针对结核分枝杆菌的表位焦点。